FOLITE- folic acid, magnesium citrate, calcium citrate, vitamin d3, n-acetyl-l-cysteine tablet

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Active ingredient:

FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8)

Available from:

Poly Pharmaceuticals, Inc.

Administration route:

ORAL

Therapeutic indications:

Folite Tablets is a dietary supplement intended for oral administration

Authorization status:

Dietary Supplement

Summary of Product characteristics

FOLITE- FOLIC ACID, MAGNESIUM CITRATE, CALCIUM CITRATE, VITAMIN D3,
N-ACETYL-L-CYSTEINE TABLET
POLY PHARMACEUTICALS, INC.
----------
FOLITE TABLET
DES CRIPTION
Folite Tablets is a dietary supplement intended for oral
administration
INDICATION AND USAGE
Folite is indicated for folic acid supplementaion and general
nutritional support. May also be
recommended for patients who are of advancing age or suffer from
improper food intake.
PRECAUTION
Folic Acid in doses above 0.1 mg daily may obscure pernicious anemia
in that hematologic remission
can occur while neurological manifestations remain progressive.
WARNINGS
KEEP THIS AN ALL MEDICATION OUT OF REACH OF CHILDREN.
Dispense in a tight, light resistant container as defined in USP/NF
with a child-resistant closure.
STORAGE
Store at 20 to 25°C (68 to 77°F) [see USP Controlled Room
Temperature|
Protect from light and moisture.
PACKAGE LABEL
DOSAGE AND ADMINISTRATION
Adults-one table daily or as directed by physician
FOLITE
folic acid, magnesium citrate, calcium citrate, vitamin d3,
n-acetyl-l-cysteine tablet
PRODUCT INFORMATION
PRODUCT T YPE
DIETARY SUPPLEMENT
ITE M CODE (SOURCE )
NHRIC:50 9 9 1-9 77
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
FO LIC ACID (UNII: 9 35E9 7BOY8 ) (FOLIC ACID - UNII:9 35E9 7BOY8 )
FOLIC ACID
1 mg
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
ACETYLCYSTEINE (UNII: WYQ7N0 BPYC)
CHO LECALCIFERO L (UNII: 1C6 V77QF41)
CALCIUM CITRATE (UNII: MLM29 U2X8 5)
SERVING SIZE :
SERVING PER CONTAINER :
Poly Pharmaceuticals, Inc.
MAGNESIUM CITRATE (UNII: RHO26 O1T9 V)
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NHRIC:50 9 9 1-9 77-30
30 in 1 BOTTLE
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
dietary supplement
0 6 /0 1/20 19
SUPPLEMENT FACTS
AMOUNT PER SERVING
% DAILY VALUE
scoring
2
color
size (solid drugs)
19 mm
shape
imprint
LABELER -
Poly Pharmaceuticals, Inc. (198